Project Details
| Short title | MK-2870-012 |
|---|---|
| Status | Active |
| Effective start/end date | 18.12.2024 → 31.12.2029 |
Fields of science
- 302024 Haematology
- 302055 Oncology
- 302014 Endocrinology
- 302022 Gynaecology
A Phase 3, Randomized, Open-label, Study to Compare the Efficacy and Safety of Adjuvant MK-2870 in Combination with Pembrolizumab (MK-3475) Versus Treatment of Physician’s Choice (TPC) in Participants With Triple-Negative Breast Cancer (TNBC) Who Received Neoadjuvant Therapy and Did Not Achieve a Pathological Complete Response (pCR) at Surgery (MK-2870-012)
- Krivic, Denis (Researcher)
- Preuß, Caroline Ines (PI)
- Schwarz, Heike Kathleen (Researcher)
- Schmitt, Clemens (Researcher)
- Kühr, Thomas (Researcher)
- Schneeweiß, Bruno (Researcher)
- Piringer, Gudrun (Researcher)
- Popp, Henning Detlef (Researcher)
- Krenosz, K. J. (Researcher)
- Ghanem, Riad (Researcher)
- Stefan, Alex (Researcher)
- Kovacsova, Judita (Researcher)
- Kausche, Lea Elisabeth (Researcher)
- Stegemann, Maike (Researcher)
- Klein, Katharina (Researcher)
- Trathnigg, Nicolas (Researcher)
- Lichtenauer, Nina (Researcher)
Project: Clinical studies › Clinical Study (Industry project)